Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and pci 34051

daunorubicin has been researched along with pci 34051 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chakrabarti, A; Duclaud, S; Erdmann, F; Hauser, AT; Heimburg, T; Jung, M; Lancelot, J; Marek, M; Melesina, J; Pierce, RJ; Robaa, D; Romier, C; Schmidt, M; Shaik, TB; Sippl, W1
Erdmann, F; Ghazy, E; Heimburg, T; Herp, D; Jung, M; Kolbinger, FR; Melesina, J; Oehme, I; Robaa, D; Romier, C; Schmidt, M; Schmidtkunz, K; Shaik, TB; Sippl, W; Witt, O; Zeyen, P1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

3 other study(ies) available for daunorubicin and pci 34051

ArticleYear
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.
    Journal of medicinal chemistry, 2016, Mar-24, Volume: 59, Issue:6

    Topics: Animals; Dose-Response Relationship, Drug; Drug Delivery Systems; Helminth Proteins; Histone Deacetylases; Humans; Larva; Models, Molecular; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides; Structure-Activity Relationship; Substrate Specificity; X-Ray Diffraction

2016
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity.
    Journal of medicinal chemistry, 2017, 12-28, Volume: 60, Issue:24

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Molecular Docking Simulation; Neuroblastoma; Repressor Proteins; Structure-Activity Relationship

2017
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023